Literature DB >> 6841534

High-performance liquid chromatographic analysis of diltiazem and its metabolite in plasma.

C Verghese, M S Smith, L Aanonsen, E L Pritchett, D G Shand.   

Abstract

A rapid, selective and reproducible high-performance liquid chromatographic method for the analysis in plasma of the calcium channel blocking agent, diltiazem, and one of its metabolites, deacetyldiltiazem is described. The method involves extraction with the methyl tert.-butyl ether of the drugs and the internal standard (verapamil), back-extraction into sulphuric acid and reversed-phase chromatography with UV detection. Over a concentration range of 10-1000 ng/ml the average coefficient of variation for diltiazem was 5.4% and for deacetyldiltiazem was 8.3%.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6841534     DOI: 10.1016/s0378-4347(00)86111-3

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

Review 1.  Diltiazem. A review of its pharmacological properties and therapeutic efficacy.

Authors:  M Chaffman; R N Brogden
Journal:  Drugs       Date:  1985-05       Impact factor: 9.546

Review 2.  Clinical pharmacokinetics of verapamil, nifedipine and diltiazem.

Authors:  H Echizen; M Eichelbaum
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

3.  Diltiazem pharmacokinetics in the rat and relationship between its serum concentration and uterine and cardiovascular effects.

Authors:  S J Downing; D Edwards; M Hollingsworth
Journal:  Br J Pharmacol       Date:  1987-08       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.